2021
DOI: 10.2174/1876386302114010014
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Effects of Two Drugs (Pregabalin & Celecoxib) on 24 hours Post-Operative Pain Intensity in Patients Undergoing Tibia Fracture Surgery

Abstract: Background: Celecoxib is widely used in post-operative cases because of its ability to reduce postoperative opioid drug use. Currently, the use of this drug is common in post-operative cases. In various studies, pregabalin was used for the management of pain after spinal surgery to reduce the need for opioids. Objectives: Since the treatment of tibia fractures and surgery is painful and has a long-term recovery, this study aimed to compare the effect of two drugs (pregabalin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
0
0
Order By: Relevance
“…Inclusion criteria included age over 18 and under 65 years and patients who continuously complained of nonspecific LBP in the last 3 months. Exclusion criteria were patients with spinal deformities (scoliosis or spondylolisthesis), discopathy, history of spinal fracture or surgery, leg length discrepancy, degenerative changes of the spinal column, rheumatoid arthritis, and hip or lower limb deformities, and use of medications that could affect bone quality ( 20 , 21 ). Finally, 148 patients were identified as eligible.…”
Section: Methodsmentioning
confidence: 99%
“…Inclusion criteria included age over 18 and under 65 years and patients who continuously complained of nonspecific LBP in the last 3 months. Exclusion criteria were patients with spinal deformities (scoliosis or spondylolisthesis), discopathy, history of spinal fracture or surgery, leg length discrepancy, degenerative changes of the spinal column, rheumatoid arthritis, and hip or lower limb deformities, and use of medications that could affect bone quality ( 20 , 21 ). Finally, 148 patients were identified as eligible.…”
Section: Methodsmentioning
confidence: 99%